17 alpha-hydroxylase deficiency: Difference between revisions
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 6: | Line 6: | ||
{{CMG}}; {{AE}} {{MJ}}<br> | {{CMG}}; {{AE}} {{MJ}}<br> | ||
{{SK}} 17 alpha-hydroxylase deficiency; 17 | {{SK}} 17-alpha-hydroxylase deficiency; 17 α-hydroxylase deficiency; 17 hydroxylase deficiency; Deficiency of steroid 17 alpha-monooxygenase; Steroid 17 alpha hydroxylase deficiency. | ||
==[[17 alpha-hydroxylase deficiency overview|Overview]]== | ==[[17 alpha-hydroxylase deficiency overview|Overview]]== |
Latest revision as of 14:16, 31 August 2017
17 alpha-hydroxylase deficiency Microchapters |
Differentiating 17 alpha-hydroxylase deficiency from other Diseases |
Diagnosis |
Treatment |
Case Studies |
17 alpha-hydroxylase deficiency On the Web |
American Roentgen Ray Society Images of 17 alpha-hydroxylase deficiency |
Risk calculators and risk factors for 17 alpha-hydroxylase deficiency |
For patient information, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
Synonyms and keywords: 17-alpha-hydroxylase deficiency; 17 α-hydroxylase deficiency; 17 hydroxylase deficiency; Deficiency of steroid 17 alpha-monooxygenase; Steroid 17 alpha hydroxylase deficiency.
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency From Other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies